USMLE - Chapter 1 - Biochemistry
-
Chromatin Structure Overview to Histone Deacetylation6Topics
-
Nucleoside and Nucleotide Basics to Base Pairing and DNA Stability5Topics
-
Introduction to Nucleotide Synthesis Inhibition to Broad-Spectrum Inhibitors and CPS Enzymes5Topics
-
Purine Metabolism and Salvage Pathways to Genetic Code: Commaless and Universal6Topics
-
DNA Replication Basics to Detailed Lagging Strand Synthesis7Topics
-
DNA Repair: Nonhomologous End Joining to DNA Repair: Mismatch Repair5Topics
-
Introns vs Exons: Basic Definitions to Visualizing Alternative Splicing and Protein Diversity4Topics
-
tRNA Structure Overview to mRNA Stop Codons6Topics
-
Introduction to DNA Mutations to Lac Operon Gene Expression States8Topics
-
Cilia Structure: Motile Cilia and Basal Body to K+ Pump Inhibition6Topics
-
Page 1 — Eukaryotic Gene Overview to Page 1 — RNA Processing: Splicing & Fate8Topics
-
Osteogenesis Imperfecta: Genetic Basis to Menkes Disease6Topics
-
Eukaryotic RNA Polymerases: Types to Splicing Diagram: Lariat & Mature mRNA7Topics
-
Flow Cytometry: Basics and Applications to ELISA: Principle and Uses4Topics
-
Protein Synthesis: Initiation Phase to Posttranslational Modifications: Chaperone Proteins6Topics
-
Karyotyping: Principles and Applications to Molecular Cloning: Process and Applications4Topics
-
Cell Cycle Phases and Regulation to p53 and Apoptosis Induction7Topics
-
Introduction to Imprinting Disorders to Visualizing Normal vs. Mutated Chromosomes6Topics
-
Rough Endoplasmic Reticulum Functions to Specific Vesicular Trafficking Proteins7Topics
-
Autosomal Dominant Inheritance to Pedigree Chart Symbols6Topics
-
Peroxisome Functions to Drugs Affecting Microtubules5Topics
-
Polyunsaturated Essential Fatty Acids to Water-Soluble Vitamins: Deficiencies and Coenzyme Functions5Topics
-
Collagen Introduction and Type I to Collagen Synthesis: Maturation and Fibril Formation6Topics
-
Vitamin B7 (Biotin): Function and Deficiency to Vitamin B9 (Folate): Deficiency, Causes, and Prevention3Topics
-
Elastin: Structure and Composition to PCR Cycle: Elongation and Repetition8Topics
-
Elastin: Structure and Composition
-
Elastin Cross-linking and α1-Antitrypsin Deficiency
-
Marfan Syndrome: Genetics and Physical Manifestations
-
Marfan Cardiovascular Complications & Homocystinuria Overview
-
Differentiating Marfan Syndrome and Homocystinuria
-
Introduction to PCR: Amplifying DNA
-
PCR Cycle: Denaturation and Annealing
-
PCR Cycle: Elongation and Repetition
-
Elastin: Structure and Composition
-
Ethanol Metabolism Overview to Pharmacological Interventions in Alcohol Metabolism5Topics
-
CRISPR to Interpreting Southern Blot Results5Topics
-
Key Metabolic Locations to Glucose Breakdown and NADPH Production4Topics
-
Transgenic Strategies in Mice to Epistasis and Aneuploidy7Topics
-
Pyruvate Dehydrogenase Deficiency to The TCA Cycle (Krebs Cycle)3Topics
-
Genetic Terms: Dominant Negative & Linkage Disequilibrium to Conditions for Hardy-Weinberg Equilibrium7Topics
-
ETC Overview to Fatty Acids in Gluconeogenesis9Topics
-
Autosomal Dominant Disorders to CFTR Channel Function Diagram11Topics
-
Autosomal Dominant Disorders
-
Autosomal Recessive Disorders
-
Cystic Fibrosis: Genetics
-
Cystic Fibrosis: CFTR Defect
-
CFTR Dysfunction and Mucus Thickening
-
Cystic Fibrosis: Diagnosis
-
CF Pulmonary Complications
-
CF Gastrointestinal and Reproductive Complications
-
CF Treatment: Mucus Clearance and Inflammation
-
CFTR Modulators in Treatment
-
CFTR Channel Function Diagram
-
Autosomal Dominant Disorders
-
Phenylketonuria: Basic Defect and BH4 Deficiency to Alkaptonuria7Topics
-
X-linked Recessive Diseases Introduction to Myotonic Dystrophy6Topics
-
Fatty Acid Synthesis Overview to Medium-Chain Acyl-CoA Dehydrogenase Deficiency4Topics
-
Mitochondrial Diseases: MELAS & MERRF to Trinucleotide Repeat Diseases: Fragile X & Friedreich Ataxia8Topics
-
Mitochondrial Diseases: MELAS & MERRF
-
Leber Hereditary Optic Neuropathy
-
Rett Syndrome Characteristics
-
Fragile X Syndrome: Genetics & Premutation
-
Fragile X Syndrome: Full Mutation Features
-
Trinucleotide Repeat Diseases: Huntington
-
Trinucleotide Repeat Diseases: Myotonic Dystrophy
-
Trinucleotide Repeat Diseases: Fragile X & Friedreich Ataxia
-
Mitochondrial Diseases: MELAS & MERRF
-
Hepatic Ketone Body Synthesis to Adipocyte Metabolism: Fed State4Topics
-
Autosomal Trisomies & Down Syndrome Overview to Second Trimester Screening & NIPT8Topics
-
Metabolic Fuel Use: Initial Exercise to Starvation After Day 3 and Stored Energy Depletion7Topics
-
Metabolic Fuel Use: Initial Exercise
-
Metabolic Fuel Use: Longer Exercise and Caloric Values
-
Fasting and Starvation: Introduction and Fed State
-
Fasting and Starvation: Between Meals
-
Starvation Days 1-3: Fuel Shifts
-
Starvation Days 1-3: Gluconeogenesis and RBCs
-
Starvation After Day 3 and Stored Energy Depletion
-
Metabolic Fuel Use: Initial Exercise
-
Genetic Disorders: Chromosomes 3-7 to Williams Syndrome6Topics
-
Dietary Lipid Absorption and Chylomicron Entry to IDL, LDL Formation, and Uptake4Topics
-
Vitamin A: Functions and Forms to Vitamin B1: Beriberi Forms7Topics
-
Vitamin B2: Function and Deficiency to Vitamin B6 Deficiency Symptoms7Topics
-
Vitamin B12: Name, Function, and Sources to Vitamin C: Excess and Toxicity7Topics
-
Vitamin D Introduction and Function to Vitamin E Deficiency and Excess Effects6Topics
-
Vitamin K Function to Marasmus: Characteristics and Visuals7Topics
-
Enzyme Terminology: Kinase & Phosphorylase to Rate-Determining Enzymes: Lipid Metabolism7Topics
-
Enzyme Terminology: Kinase & Phosphorylase
-
Enzyme Terminology: Phosphatase, Dehydrogenase, Hydroxylase
-
Enzyme Terminology: Carboxylase, Mutase, Synthase/Synthetase
-
Rate-Determining Enzymes: Glycolysis, Gluconeogenesis, TCA Cycle
-
Rate-Determining Enzymes: Glycogenesis, Glycogenolysis, HMP Shunt
-
Rate-Determining Enzymes: Nucleotide Synthesis, Urea Cycle
-
Rate-Determining Enzymes: Lipid Metabolism
-
Enzyme Terminology: Kinase & Phosphorylase
-
ATP Production Pathways to Hexokinase vs Glucokinase: Kinetics & Regulation5Topics
-
Glycolysis Net Reaction to PDC: α-Ketoglutarate & Arsenic7Topics
-
Introduction to Pentose Phosphate Pathway to G6PD Deficiency: Biochemical Mechanism of Oxidative Stress7Topics
-
Essential Fructosuria to Galactose Metabolism Pathway & Summary6Topics
-
Sorbitol Pathway and Diabetic Complications to Acidic and Basic Amino Acids6Topics
-
Urea Cycle Introduction to Hyperammonemia Treatment5Topics
-
Ornithine Transcarbamylase Deficiency to Catecholamine Synthesis and Degradation5Topics
-
Homocystinuria: Genetic Causes to Methylmalonic Acidemia: Deficiency & Metabolism6Topics
-
Glucagon to Glycogen Disorders and Enzymes6Topics
-
Introduction to Glycogen Storage Diseases to McArdle Disease (Type V)6Topics
-
Lysosomal Storage Diseases Intro & Tay-Sachs to Lysosomal Storage Disease Pathway6Topics
-
Key Enzymes in Lipid Transport - Part 1 to Major Apolipoproteins - Part 25Topics
-
Lipoprotein Functions: Chylomicron & VLDL to Familial Dyslipidemias: Dysbetalipoproteinemia & Hypertriglyceridemia5Topics
Cell Cycle Phases and Regulation to p53 and Apoptosis Induction
Content August 26, 2025
Cell Cycle Phases and Checkpoints
Checkpoints control transitions between phases of cell cycle. This process is regulated by cyclins, cyclin-dependent kinases (CDKs), and tumor suppressors. M phase (shortest phase of cell cycle) includes mitosis (prophase, prometaphase, metaphase, anaphase, telophase) and cytokinesis (cytoplasm splits in two). G0 is of variable duration.
Regulation of Cell Cycle: Cyclin-CDK Complexes
| Regulation of Cell Cycle | Description |
|---|---|
| Cyclin-dependent kinases | Constitutively expressed but inactive when not bound to cyclin. |
| Cyclin-CDK complexes | Cyclins are phase-specific regulatory proteins that activate CDKs when stimulated by growth factors. The cyclin-CDK complex can then phosphorylate other proteins (eg, Rb) to coordinate cell cycle progression. This complex must be activated/inactivated at appropriate times for cell cycle to progress. |
Regulation of Cell Cycle: Tumor Suppressors
| Regulation of Cell Cycle | Description |
|---|---|
| Tumor suppressors | p53 → p21 induction → CDK inhibition → Rb hypophosphorylation (activation) → G1-S progression inhibition. Mutations in tumor suppressor genes can result in unrestrained cell division (eg, Li-Fraumeni syndrome). Growth factors (eg, insulin, PDGF, EPO, EGF) bind tyrosine kinase receptors to transition the cell from G1 to S phase. |
Cell Types and Their Cell Cycle Status
| Cell Types | Description | Examples |
|---|---|---|
| Permanent | Remain in G0; regenerate from stem cells. | Neurons, skeletal and cardiac muscle, RBCs. |
| Stable (quiescent) | Enter G1 from G0 when stimulated. | Hepatocytes, lymphocytes, PCT, periosteal cells. |
| Labile | Never go to G0; divide rapidly with a short G1. | Bone marrow, gut epithelium, skin, hair follicles, germ cells. |
Cell Cycle Overview and G1 Restriction Point
#boundingbox
This diagram illustrates the cell cycle, showing the interphase stages of G1, S (DNA synthesis), and G2, followed by the M phase (mitosis and cytokinesis). Cells can also enter a quiescent G0 phase. The G1 restriction point is a critical control point, modulated by Rb and p53, which determines whether a cell proceeds to DNA synthesis or exits the cycle.
DNA Damage Response and Cell Cycle Arrest
#boundingbox
This section of the diagram shows how DNA damage triggers the activation of p53. Activated p53 then induces p21, which acts to inhibit Cyclin-CDK complexes, leading to cell cycle arrest. This mechanism prevents cells with damaged DNA from replicating. Notably, HPV E6 can lead to a loss of function in p53, disrupting this critical tumor suppressor pathway.
p53 and the Intrinsic Apoptosis Pathway
#boundingbox
Beyond cell cycle arrest, p53 also plays a role in programmed cell death. In response to severe damage, p53 can inhibit anti-apoptotic proteins like BCL-2 and BCL-XL. This inhibition allows pro-apoptotic proteins, BAX and BAK, to become active, leading to caspase activation and ultimately, apoptosis via the intrinsic pathway. This ensures that severely damaged cells are eliminated, preventing their potential to become cancerous.
Topics Covered:
- Cell Cycle Phases and Regulation
- Cyclin-CDK Complex Function
- Tumor Suppressor Mechanisms
- Classification of Cell Types by Division
- Cell Cycle Phases and G1 Control
- p53 and Cell Cycle Arrest
- p53 and Apoptosis Induction